As a key regulator of the alternative complement pathway, abnormalities of CFH have been associated with many autoimmune diseases, including aHUS, C3 nephropathy, and SLE [12, 13, 23, 31]. The gene discussed is CFH; the disease is atypical hemolytic-uremic syndrome.